NANOBIOTIX (EPA:NANO) Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
Transparency directive : regulatory news
02/06/2024 16:00
source : webdisclosure.com
NANOBIOTIX's latest news
17/12/2024 22:15
11/12/2024 22:15
09/12/2024 22:15
31/10/2024 08:30
11/10/2024 22:15
18/09/2024 22:15
04/09/2024 22:15
03/09/2024 22:15
08/08/2024 22:15
09/07/2024 22:15
Other stories
26/12/2024 11:04
26/12/2024 11:33
26/12/2024 09:37
26/12/2024 08:00
25/12/2024 21:00
25/12/2024 16:10
26/12/2024 03:22
25/12/2024 18:44
26/12/2024 06:58
25/12/2024 19:22
26/12/2024 07:09
25/12/2024 23:06
26/12/2024 06:43
26/12/2024 11:30
26/12/2024 08:15
26/12/2024 06:00
26/12/2024 09:27
26/12/2024 01:01
26/12/2024 10:37
24/12/2024 11:58
24/12/2024 13:03
26/12/2024 02:44
25/12/2024 23:31
25/12/2024 21:26
26/12/2024 09:00
26/12/2024 10:07
26/12/2024 07:00
26/12/2024 05:59
26/12/2024 09:01
26/12/2024 08:50
24/12/2024 15:07
24/12/2024 15:56
24/12/2024 20:00
25/12/2024 13:22
26/12/2024 08:00
25/12/2024 20:21
26/12/2024 09:00
26/12/2024 10:12